Rabbit Bone Marrow Mesenchymal Stem Cells
Introduction
Bone marrow mesenchymal stem cells (BMSCs) are a type of multipotent stem cell residing in the bone marrow stroma. Due to their strong proliferative capacity and immunomodulatory properties, BMSCs are widely applied in tissue engineering, cell therapy, and gene therapy.
As a research hotspot, rabbit bone marrow mesenchymal stem cells are commonly used in regenerative medicine and tissue engineering, particularly in studies involving bone, cardiovascular, and nervous system disorders.
OriCell™ Rabbit Bone Marrow Mesenchymal Stem Cells are isolated from the bone marrow of healthy New Zealand white rabbits. These cells exhibit robust proliferation and multipotent differentiation potential, making them a valuable cell model for studying proliferation, aging, immune regulation, differentiation, and transplantation.
When citing our products in academic publications, please use the following format: "OriCell™ [Product Name] + [Catalog Number], from Cyagen Biosciences."
Product Information
| Product Name | OriCell™ Rabbit Bone Marrow Mesenchymal Stem Cells |
| Catalog Number | RBXMX-01001 |
| Amount of Cells | 1×106 cells/vial |
| Passage Number | P2 |
| Storage at | Liquid Nitrogen (-196 ℃) |
QC
- Pass the detection of bacteria, fungi, mycoplasma, and endotoxins.
- Verified by cell recovery testing, with a post-thaw viability of >80%.
- Verified by cell cycle analysis, with a doubling time < 72 h.
- Verified by flow cytometry: Positive for Integrin beta 1, CD44 and VCAM1 (> 70%); Negative for C-Kit, CD31 and CD34 (< 5%).
- Proven differentiation potential into osteoblasts, adipocytes, and chondrocytes.
Please refer to "COA" for details.
General Handling Principles
- Maintain strict aseptic technique. Ensure complete sterility throughout all procedures, particularly within the laminar flow hood and incubator.
- Follow standardized protocols. Adhere strictly to the product manual. Implement rigorous control over experimental variables and include appropriate parallel controls.
- Use high-quality consumables and reagents. This product requires culture vessels suitable for adherent growth, and the reuse of these vessels is not recommended. The reagents used must be validated for reliability, cell compatibility, and batch-to-batch consistency.
- Prioritize low-passage cells. Generally, BMSCs have limited ability to proliferate in vitro and cannot maintain their differentiation potential for a long time. Leveraging our extensive cell culture expertise and optimized culture systems, OriCell™ Rabbit Bone Marrow Mesenchymal Stem Cells can be subcultured for more than 5 passages while maintaining their phenotypic integrity and meeting our rigorous quality control standards. However, we always recommend using low-passage cells for research applications.
- Optimize seeding density and subculture. The recommended seeding density for OriCell™ Rabbit Bone Marrow Mesenchymal Stem Cells is (2.5–4) × 10⁴ viable cells/cm². Since cell growth is highly dependent on donor characteristics and culture conditions, we recommend adjusting the split ratios based on the actual performance of each specific lot and passage.
Warm Notice: The cryopreservation medium of this product contains DMSO, which has potential risks. Please handle it carefully.
- A 3D-printed scaffold with MoS2 nanosheets for tumor therapy and tissue regeneration. 点击索取文献 ››
- Prevention of glucocorticoid-associated osteonecrosis by intravenous administration of mesenchymal stem cells in a rabbit model. 点击索取文献 ››
- A bifunctional scaffold with CuFeSe2 nanocrystals for tumor therapy and bone reconstruction. 点击索取文献 ››
- A Programmable, Fast-fixing, Osteo-regenerative, Biomechanically Robust Bone Screw. 点击索取文献 ››
- Bone-Inspired Tube Filling Decellularized Matrix of Toad Cartilage Provided an Osteoinductive Microenvironment for Mesenchymal Stem Cells to Facilitate the Radius Defect Repair of Rabbit. 点击索取文献 ››
-
A 3D-printed scaffold with MoS2 nanosheets for tumor therapy and tissue regeneration.
NPG Asia Materials 9,e376 (2017) IF = 9.157 Year 2017
-
Prevention of glucocorticoid-associated osteonecrosis by intravenous administration of mesenchymal stem cells in a rabbit model.
BMC Musculoskeletal Disorders 18:480 (2017) IF = 1.739 Year 2017
-
A bifunctional scaffold with CuFeSe2 nanocrystals for tumor therapy and bone reconstruction.
Biomaterials 160:92-106 (2017) IF = 8.402 Year 2017
-
A Programmable, Fast-fixing, Osteo-regenerative, Biomechanically Robust Bone Screw.
Acta Biomaterialia PMID: 31857258 (2019) IF = 6.638 Year 2019
-
Bone-Inspired Tube Filling Decellularized Matrix of Toad Cartilage Provided an Osteoinductive Microenvironment for Mesenchymal Stem Cells to Facilitate the Radius Defect Repair of Rabbit.
Biotechnology Journal Doi: 10.1002/biot.202000004. IF = 3.543 Year 2020